Previous 10 | Next 10 |
LONDON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a paper in JAMA Psychiatry that dem...
Earlier this month, the governor of Massachusetts filed a measure that would modernize services, increase benefits and promote inclusivity for veterans in the state. Governor Maura Healey filed the resolution, christened the Hero Act, on Veterans Day. The measure would establish a private-pub...
2023-11-29 18:55:54 ET Summary ATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various clinical trial phases, showing promising results. ...
2023-11-29 16:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-28 09:20:00 ET November 28, 2023 (Investorideas.com Newswire) investorideas.com, a global news source covering leading sectors including marijuana and psychedelic stocks releases a special edition of the top rated Investor Ideas potcast (Cannabis Podcast). In today's episode...
Efforts to get plant-based psychedelic substances legalized in the state of Massachusetts may have hit a snag after one regulation on gathering signatures was violated. The regulation in question was the printing of the logo of a labor union on ballot sheets, which may have invalidated the whol...
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the 6th Annual Evercore ISI HealthCONx Confer...
Late last year, voters in the state of Colorado approved the Natural Medicine Health Act , which decriminalized the personal use of substances such as psilocybin mushrooms for those aged 21 years and older. This year, another measure that legalized testing laboratories for psychedelic substanc...
UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in the UK, including at the newly opened Centre for Mental Health Research and Innovation in London, developed in partnership with...
The United States Department of Veteran Affairs (VA) has expressed that it is willing to consider the use of psychedelics in post-traumatic stress disorder (PTSD) treatment. In a statement issued to KDKA-TV Investigates, the agency said that it is open to the use of hallucinogenics to treat PTS...
News, Short Squeeze, Breakout and More Instantly...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...
New research has determined that psilocybin may impact the brain. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, it distorts an individual’s perception of time, among other changes. Researchers have observed that in animals, psilocyb...